MIRA INFORM REPORT

 

 

Report Date :

19.04.2012

 

IDENTIFICATION DETAILS

 

Name :

COREY ORGANICS PRIVATE LIMITED (w.e.f. 06.07.2009)

 

 

Formerly Known As :

COREY ORGANICS LIMITED

 

 

Registered Office :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500 038, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

01.03.1996

 

 

Com. Reg. No.:

01-023399

 

 

Capital Investment / Paid-up Capital :

Rs.21.739 millions

 

 

CIN No.:

[Company Identification No.]

U23231AP1996PTC023399

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDC00743B

 

 

PAN No.:

[Permanent Account No.]

AABCC3624L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of Bulk Drug Intermediates and Fine Chemicals.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (35)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 148000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for small to mediocre business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office/ Admin Office :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500 038, Andhra Pradesh, India

Tel. No.:

91-40-23715528

Fax No.:

91-40-23701738 

E-Mail :

coreyorganics@gmail.com

info@coreyorganics.com

info@chavadipharma.com

Website :

http://www.coreyorganics.com

 

 

Factory 1 :

Shed No.1 and Plot No.23, IDA Kothur, Kothur (V and M), Mahaboobnagar (District), Andhra Pradesh, India

Tel. No.:

91-8548-256246

Fax No.:

91-8548-256246

 

 

Factory 2 :

Plot No.35, Road No.10, Jawahar Lal Nehru Pharma City, Parawada, Vishakapatnam – 531 019, Andhra Pradesh, India

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Devi Reddy Raja Kumar Reddy

Designation :

Managing Director

Address :

H.No.100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

20.08.1956

Date of Appointment :

01.03.1996

DIN No.:

00059112

Other Directorship :

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Company Status

Defaulting status

1

U23231AP1996PTC023399

Corey Organics Private Limited

Managing director

01-04-06

01-03-96

Active

NO

2

U24110AP1996PTC023074

Sri Chavadi Pharma Private Limited

Director

30-09-05

30-09-05

Active

NO

 

 

Name :

Ms. Devereddy Vidna Reddy

Designation :

Director

Address :

H.No.100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

27.04.1986

Date of Appointment :

30.09.2005

DIN No.:

00065644

Other Directorship :

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Company Status

Defaulting status

1

U23231AP1996PTC023399

Corey Organics Private Limited

Director

30-09-05

30-09-05

Active

NO

2

U24232AP2010PTC068382

Sai Sreyas Pharmaceutical Private Limited

Additional director

15-12-11

15-12-11

Active

NO

 

 

Name :

Mr. Vijayakumar Reddy Devireddi

Designation :

Director

Address :

4/468-2, Up Stair, Vivekananda Nagar, Kadapa, Andhra Pradesh, India

Date of Birth/Age :

01.06.1950

Date of Appointment :

30.09.1999

DIN No.:

02653753

 

 

Name :

Ms. Deepna Devireddy

Designation :

Director

Address :

H.No.100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

19.02.1989

Date of Appointment :

10.02.2011

DIN No.:

03245840

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

 

No. of Shares

D. Rajakumar Reddy

 

648838

D. Sailaja 

 

278991

C. Giridhar Reddy

 

219

D. Vijaya Kumar Reddy

 

8300

C. Santha

 

15700

D. Deepna

 

172178

D. Vidna

 

597440

B. Dileep Kumar Reddy

 

592500

B. Saraswathi

 

27200

D. Laxmidevamma

 

14000

D. Swaroopa

 

39900

D. Jayalakshmi

 

33300

K. Maheswara Reddy

 

26000

CH. Nageswara Rao

 

29400

Total

 

2483966

 

As on 30.09.2011

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Bulk Drug Intermediates and Fine Chemicals.

 

 

Products :

v      Pyridine Derivatives

v      Fine Chemicals

v      API Intermediates

v      Active Pharma Ingredients

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

 

2010-11

Licensed Capacity, Installed Capacity

150 Tones

Actual Production

129.94 Tones

 

 

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

v      State Bank of Hyderabad, 11 60 2, 1st Floor, MJR Complex, NH-7, Shamshabad, SSI Branch, Ranga Reddy District, Hyderabad – 501 218, Andhra Pradesh, India

v      Axis Bank

v      HDFC Bank

 

 

Facilities :

 

Secured Loans

31.03.2011

Rs. In Millions

31.03.2010

Rs. In Millions

a) Cash Credit (State Bank of Hyderabad Shamshabad) 

34.962

35.779

b) SME Credit Plus Loan

2.394

0.000

c) Vehicle Loan from Axis Bank

0.328

0.844

d) Life Insurance Corporation of India

2.250

2.250

e) Term Loans (State Bank of Hyderabad Shamshabad) 

20.621

9.173

f) APSFC Loan

9.900

0.000

Total

70.455

48.046

 

Unsecured Loans

31.03.2011

Rs. In Millions

31.03.2010

Rs. In Millions

Bajaj Auto Finance Limited

0.839

1.699

Barclays Investments and Loans (India)

1.448

2.000

C. Giridhar Reddy

0.000

0.001

D. Rajakumar Reddy

0.090

0.027

D. Sailaja 

0.000

0.109

D. Deepna Reddy

0.000

0.004

D. Vidna Reddy

0.000

0.002

D. Vijaya Kumar Reddy

0.000

0.001

D. Swaroopa

0.399

0.000

D. Jayalakshmi

0.333

0.000

K. Maheswara Reddy

0.260

0.000

CH. Nageswara Rao

0.294

0.000

HDFC Bank Loan

0.997

1.395

Indiabulls Financial Services Limited

1.540

2.000

Magma Fincorp Limited

1.091

1.813

D. Laxmi Devamma

0.140

0.000

Total

7.431

9.051

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Sesha Prasad and Company

Chartered Accountants

Address :

Flat No.202, IInd Floor, #9-14-7/10, Amma Apartments, VIP Road, CBM Compound, Visakhapatnam – 530 003, Andhra Pradesh, India

Tel. No.:

91-40-23551573/ 1873, 27540181/ 82/ 83

E-Mail :

info@seshaprasad.com

Income-tax PAN of auditor or auditor's firm :

AADCM8135A

 

 

Associates Company :

Sri Chavadi Pharma Private Limited

 

 

CAPITAL STRUCTURE

 

As on 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

2500000

Equity Shares

Rs.10/- each

Rs.25.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

2483966

Equity Shares

Rs.10/- each

Rs.24.840 millions

 

 

 

 

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

2500000

Equity Shares

Rs.10/- each

Rs.25.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

2173866

Equity Shares

Rs.10/- each

Rs.21.739 millions

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

21.739

11.480

7.480

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

15.320

10.238

9.086

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

37.059

21.718

16.566

LOAN FUNDS

 

 

 

1] Secured Loans

70.455

48.046

30.850

2] Unsecured Loans

7.431

9.051

0.000

TOTAL BORROWING

77.886

57.097

30.850

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

114.945

78.815

47.416

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

50.967

55.823

13.591

Capital work-in-progress

19.849

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERRED TAX ASSETS

0.979

0.735

1.194

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

42.495

25.412

6.009

 

Sundry Debtors

44.284

31.353

18.241

 

Cash & Bank Balances

0.527

0.365

0.032

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

24.147

12.204

37.532

Total Current Assets

111.453

69.334

61.814

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

60.805

43.140

24.736

 

Other Current Liabilities

3.166

1.991

1.810

 

Provisions

4.332

2.049

2.637

Total Current Liabilities

68.303

47.180

29.183

Net Current Assets

43.150

22.154

32.631

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.103

0.000

 

 

 

 

TOTAL

114.945

78.815

47.416

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Sales

205.490

100.733

76.663

 

 

Conversion Charges

5.869

17.135

20.177

 

 

Other Income

0.790

0.558

0.884

 

 

TOTAL                                     (A)

212.149

118.426

97.724

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Raw material consumed

128.783

65.139

53.404

 

 

Manufacturing Expenses

54.405

38.377

28.796

 

 

Increase/ Decrease in Stock

(7.832)

(8.052)

0.229

 

 

Administrative Expenses

11.268

9.254

5.531

 

 

Preoperative expenditure written off

0.103

0.026

0.000

 

 

TOTAL                                     (B)

186.727

104.744

87.960

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

25.422

13.682

9.764

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

9.137

4.876

2.786

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

16.285

8.806

6.978

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

7.116

5.145

1.956

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

9.169

3.661

5.022

 

 

 

 

 

Less

TAX                                                                  (H)

3.070

1.166

1.629

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

6.099

2.495

3.393

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

7.957

7.054

4.875

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

General Reserve

0.610

0.249

0.339

 

 

Proposed Dividend

0.869

1.148

0.748

 

 

Corporate Dividend Tax

0.148

0.195

0.127

 

BALANCE CARRIED TO THE B/S

12.429

7.957

7.054

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

0.000

4.086

14.980

 

TOTAL EARNINGS

0.000

4.086

14.980

 

 

 

 

 

 

Earnings Per Share (Rs.)

2.81

2.17

4.54

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

2.87

2.11

3.47

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

4.46

3.63

6.55

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.65

2.93

6.66

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.25

0.17

0.30

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

3.94

4.80

3.62

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.63

1.47

2.12

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes 

4) Premises details

No

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter’s background

Yes

8) No. of employees

No 

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

No 

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter involved in

--

23) Banking Details

Yes

24) Banking facility details

Yes 

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 

Note:

The registered office of the company has been shifted from Shed No 1, IDA, Kottur, Andhra Pradesh to the present address w.e.f. 29.07.2010.

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U23231AP1996PTC023399

Name of the company

COREY ORGANICS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500 038, Andhra Pradesh, India

E-Mail: coreyorganics@gmail.com

This form is for

Modification of charge

Charge identification number of the modified 

90133934

Type of charge

Immovable Property

Book Debts

Movable Property (not being pledge)

Floating Charge

Particular of charge holder

State Bank of Hyderabad, 11 60 2, 1st Floor, MJR Complex, NH-7, Shamshabad, SSI Branch, Ranga Reddy District, Hyderabad – 501 218, Andhra Pradesh, India

E-Mail: sbhifb_hyd@yahoo.com

Nature of description of the instrument creating or modifying the charge

1. Enhancement in Credit Facilities

2. Letter of confirmation for creation of mortgage by deposit of title deeds

3. Memorandum of deposit of title deeds.

4. Memorandum of deposit of title deeds. (Extension/Second Charge)

Date of instrument Creating the charge

14.07.2011

Amount secured by the charge

Rs.124.500 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

a)15.50% p.a. (at 6.50% above base rate) floating for cash credit

b)15.00% p.a. (at 5.50% above base rate) floating for term loan

 

Terms of Repayment:

a)Working capital payable on demand

 

Margin:

a) 25% on Raw material, Stocks in process, Finished Goods

b) 40% on Receivables (90 days)

c) 15% on Letter of Credit

 

Extent and Operation of the charge:

Extent of charge is on movable and immovable properties as per the agreement

Short particulars of the property charged

Industrial Land and Building at Shed No-1, Plot No-8/1, 8/3 and 8/4 in Sy. No.193, 139 and 140, situated at Industrial Development Area, Kothur Village, Shadnagar Mandal, Mahaboobnagar Industrial Land and Building at Plot No.23, in Sy. No.103, Situated at Industrial Development area, Kothur Village, Shadnagar Mandal, Mahaboobnagar Industrial Land and Building in Sy. No.103, Plot No.22, Situated at Industrial Development area, Kothur Village, Shadnagar Mandal, Mahaboobnagar.

EM of industrial land and building and machinery in Sy. No.103, Shed No.9, Phase-1, Industrial Area, Kothur Village and Mandal, Mahaboobnagar standing in the name of Sri Gandi Anjaneya Ice Plant.

Hypothecation  of raw materials, stock in process, receivables/ book debts, finished goods , current assets, land and building,  plant and machinery

Date of latest modification prior to the present modification

21.07.2010

Particulars of the present modification 

Limit enhanced from Rs.73.500 millions to Rs.124.500 millions.

 

FIXED ASSETS:

 

v      Land

v      Buildings

v      Plant and Machinery

v      Furniture and Fixtures

v      Lab Equipments

v      Electrical Equipments

v      Office Equipments (Computers)

v      Pollution Maintenance Equipment

v      Vehicles

 

WEBSITE DETAILS:

 

PROFILE:

 

Subject, was formed in 1996 by Mr. D. Rajkumar Reddy, and is engaged in the business of manufacturing bulk drug intermediates and fine chemicals and has crossed a decade in its line of business with reaching targeted goals consistently over the years.

 

Subject has 2 manufacturing units well accompanied with CGMP standards and regularly manufactures Intermediates of Clopidogrel [ Form1 and From 2] Diltiazem, Iteraconazole, Losartan Pottasium , Risperidone , Olanzipine and more, subject is one of the manufacturer of Pyridine Derivatives and API intermediates in India.

 

Its associates company Sri Chavadi Pharma Private Limited is having plant in the same location also manufactures Fine Chemicals.

 

Subject has well manufacturing facilities and the affairs of the Company are taken care by Persons with handful of experience and expertise in the line of Bulk drugs and its intermediates manufacturing to facilitate healthy business to the Clients sharing worldwide.

 

Subject has been Awarded "PEARLS OF ANDHARA PRADESH" for "District Level Award to Small Scale Entrepreneurs in the State" for 2003-04 by Govt. of Andhra Pradesh, Industries and Commerce Department.

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.50

UK Pound

1

Rs.81.99

Euro

1

Rs.67.54

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

35

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.